---
agency: Department of the Treasury
applicant_types: []
assistance_types:
- Tax Expenditures
authorizations: []
beneficiary_types: []
categories:
- Tax Expenditures - Health
cfda: TC.138
fiscal_year: '2024'
grants_url: null
improper_payments: null
is_subpart_f: null
layout: program
objective: The baseline tax system would not allow credits for particular activities,
  investments, or industries. In contrast, under current law drug firms can claim
  a tax credit of 25 percent of the costs for clinical testing required by the Food
  and Drug Administration for drugs that treat rare physical conditions or rare diseases.
obligations: null
other_program_spending: '[{"x":"2023","outlays":0.0,"forgone_revenue":1740000000.0},{"x":"2024","outlays":0.0,"forgone_revenue":1930000000.0},{"x":"2025","outlays":0.0,"forgone_revenue":2150000000.0}]'
outlays: null
permalink: /program/TC.138.html
popular_name: ''
program_type: tax_expenditure
results: []
rules_regulations: null
sam_url: null
sub-agency: Internal Revenue Service (IRS)
title: Tax credit for orphan drug research
usaspending_url: null
---
